Bolar's perphenazine/amitriptyline
Executive Summary
Firm is first to receive approval of a generic version of MS&D's Triavil. FDA approved the product Aug. 25 in dosages of 2 mg/10 mg, 2 mg/25 mg, 4 mg/10 mg, and 4 mg/25 mg. Bolar said initial shipments of the product were "in excess of $1 mil.".